Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DARRYL C DEVIVO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1801806070
CMS profile
728325
Location
NEW YORK, NY

General Payments · PY2018–2023

$72,227.44

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$13,758.87

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
AveXis $13,758.87 14

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,106.73 15
PY2019 $17,062.40 21
PY2020 $11,864.27 21
PY2021 $9,547.64 18
PY2022 $10,887.53 42
PY2023 $13,758.87 14

Payment records · PY2023 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $33.33 03/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915799 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $25.00 03/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915801 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $187.50 03/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915803 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $853.33 03/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915805 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $640.00 03/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915807 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $4,128.00 04/14/2023 Honoraria Undisputed 01/23/2026 1016915809 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $56.25 04/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915811 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $2,210.53 05/31/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915813 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $1,199.79 06/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915815 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $56.25 06/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915817 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $60.00 06/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915819 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $45.00 06/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915821 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $135.89 09/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1016915823 CMS
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $4,128.00 10/20/2023 Honoraria Undisputed 01/23/2026 1016915825 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.